BAA contract

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201710065C
Awardee
Awarding agency
Obligated
$2,334,352

Award facts

Opportunity
Contract value 100% obligated
$2,334,352.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 55 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
State College, PA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$153,227
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope 1 $0
Original award $2,487,579

About this award

This is a definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Chromatan Inc., a for-profit manufacturer, on August 30, 2017. The contract, which is a Broad Agency Announcement (BAA) contract with a firm fixed price type, has a potential value of $2,334,352.00 and is set to be completed by November 30, 2020. The contract does not have a set-aside designation and the place of performance is located in State College, Pennsylvania.

Quick answers

Who was awarded contract HHSF223201710065C?

HHSF223201710065C was awarded to Chromatan Inc. by Food and Drug Administration (Department of Health and Human Services) on August 30, 2017.

How much is contract HHSF223201710065C worth?

The government has obligated $2,334,352 on HHSF223201710065C.

Was contract HHSF223201710065C competed?

The extent of competition for HHSF223201710065C was full and open competition. The government received 55 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award